Zhejiang Huahai Pharmaceutical operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Huahai Pharmaceutical with three other
companies in this sector in China:
Tong Ren Tang Technologies Company Limited
sales of 5.03 billion Chinese Renmimbi [US$722.32 million]
of which 70%
was The Company),
China Medical System Holdings Limited
(5.35 billion Chinese Renmimbi [US$768.84 million]
of which 100%
was Pharmaceutical Products), and
Zhejiang Conba Pharmaceutical Co., Ltd.
(5.29 billion Chinese Renmimbi [US$760.70 million]
of which 96%
Zhejiang Huahai Pharmaceutical reported sales of 5.00 billion Chinese Renmimbi (US$718.99 million)
December of 2017.
increase of 22.2%
versus 2016, when the company's sales were 4.09 billion Chinese Renmimbi.
Sales at Zhejiang Huahai Pharmaceutical have increased during each of the previous five years
(and since 2012, sales have increased a total of 148%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
1,953.1% in 2017, from
12,478.64 Chinese Renmimbi to 256,205.16 Chinese Renmimbi.
Zhejiang Huahai Pharmaceutical also saw significant increases in sales in
Drug Sale (up 34.4% to 2.64 billion Chinese Renmimbi)
Technical Service (up 212.8% to 48.07 million Chinese Renmimbi)
Other Operating (up 70.3% to 20.29 million Chinese Renmimbi)
Not all segments of Zhejiang Huahai Pharmaceutical experienced an increase in sales in 2017:
sales of Import and Export Trade fell 31.5% to 150.24 million Chinese Renmimbi.